Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas
Meningiomas, the most frequent benign intracranial and intraspinal types of tumors are normally removed by surgery. Complications can occur when the tumor is critically localized and cannot be completely removed or when comorbidities of the mostly elder patients increase the general surgical risk. T...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Springer New York LLC
2013
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 20413caa a22017777a 4500 | ||
|---|---|---|---|
| 001 | PAPER-11465 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204137.0 | ||
| 008 | 190411s2013 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84879341119 | |
| 024 | 7 | |2 cas |a caspase 3, 169592-56-7; curcumin, 458-37-7; thymidine, 50-89-5; Antineoplastic Agents; Curcumin | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a JNODD | ||
| 100 | 1 | |a Curic, S. | |
| 245 | 1 | 0 | |a Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas |
| 260 | |b Springer New York LLC |c 2013 | ||
| 270 | 1 | 0 | |m Renner, U.; Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Kraepelinstr. 10, 80804 Munich, Germany; email: renner@mpipsykl.mpg.de |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Mawrin, C., Perry, A., Pathological classification and molecular genetics of meningiomas (2010) J Neurooncol, 99, pp. 379-391. , 20809251 10.1007/s11060-010-0342-2 1:CAS:528:DC%2BC3cXht1Sru77L | ||
| 504 | |a Choy, W., Kim, W., Nagasawa, D., Stramotas, S., Yew, A., Gopen, Q., Parsa, A.T., Yang, I., The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments (2011) Neurosurg Focus, 30, p. 6. , 21529177 | ||
| 504 | |a Marosi, C., Hassler, M., Roessler, K., Reni, M., Sant, M., Mazza, E., Vecht, C., Meningioma (2008) Crit Rev Oncol Hematol, 67, pp. 153-171. , 18342535 10.1016/j.critrevonc.2008.01.010 | ||
| 504 | |a Louis, D.N., Scheithauer, B.W., Budka, H., Von Deimling, A., Kepes, J.J., Meningiomas (2000) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System, pp. 176-184. , Kleihues W.K. Cavenee (eds) IARC Press Lyon | ||
| 504 | |a Ruttledge, M.H., Sarrazin, J., Rangaratnam, S., Phelan, C.M., Twist, E., Merel, P., Delattre, O., Collins, V.P., Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas (1997) Nat Genet, 6, pp. 180-184. , 10.1038/ng0294-180 | ||
| 504 | |a Gutmann, D.H., Donahoe, J., Perry, A., Lemk, N., Gorse, K., Kittiniyom, K., Rempel, S.A., Newsham, I.F., Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas (2000) Hum Mol Genet, 9, pp. 1495-1500. , 10888600 10.1093/hmg/9.10.1495 1:CAS:528:DC%2BD3cXksF2nu7c%3D | ||
| 504 | |a Smith, M.J., O'Sullivan, J., Bhaskar, S.S., Hadfield, K.D., Poke, G., Caird, J., Sharif, S., Evans, D.G., Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas (2013) Nat Genet, 45, pp. 295-298. , 23377182 10.1038/ng.2552 1:CAS:528:DC%2BC3sXhvFWjtL0%3D | ||
| 504 | |a Clark, V.E., Erson-Omay, E.Z., Serin, A., Yin, J., Cotney, J., Ozduman, K., Avsar, T., Günel, J.M., Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO (2013) Science, 339, pp. 1077-1080. , 23348505 10.1126/science.1233009 1:CAS:528:DC%2BC3sXjtVGjsb4%3D | ||
| 504 | |a Perry, A., Cai, D.X., Scheithauer, B.W., Swanson, P.E., Lohse, C.M., Newsham, I.F., Weaver, A., Gutmann, D.H., Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: A correlative immunohistochemical study of 175 cases (2000) J Neuropathol Exp Neurol, 59, pp. 872-879. , 11079777 1:CAS:528:DC%2BD3cXotVKnu74%3D | ||
| 504 | |a Bostrom, J., Meyer-Puttlitz, B., Wolter, M., Blaschke, B., Weber, R.G., Lichter, P., Ichimura, K., Reifenberger, G., Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18 INK4c) in atypical and anaplastic meningiomas (2001) Am J Pathol, 159, pp. 661-669. , 11485924 10.1016/S0002-9440(10)61737-3 1:CAS:528:DC%2BD3MXms1Wit7w%3D | ||
| 504 | |a Dutour, A., Kumar, U., Panetta, R., Quafik, L., Fina, F., Sasi, R., Patel, Y.C., Expression of somatostatin receptor subtypes in human brain tumors (1998) Int J Cancer, 76, pp. 620-627. , 9610716 10.1002/(SICI)1097-0215(19980529)76:5<620: AID-IJC2>3.0.CO;2-S 1:STN:280:DyaK1c3nt1antQ%3D%3D | ||
| 504 | |a Barresi, V., Angiogenesis in meningiomas (2011) Brain Tumor Pathol, 28, pp. 99-106. , 21290262 10.1007/s10014-010-0012-2 1:CAS:528:DC%2BC3MXhtFGjs7rM | ||
| 504 | |a Norden, A.D., Drappatz, J., Wen, P.Y., Targeted drug therapy for meningiomas (2007) Neurosurg Focus, 23, p. 12. , 17961036 10.3171/FOC-07/10/E12 | ||
| 504 | |a Wen, P.Y., Quant, E., Drappatz, J., Beroukhim, R., Norden, A.D., Medical therapies for meningiomas (2010) J Neurooncol, 99, pp. 365-378. , 20820875 10.1007/s11060-010-0349-8 1:CAS:528:DC%2BC3cXht1Sru77E | ||
| 504 | |a Kunnumakkara, A.B., Anand, P., Aggarwal, B.B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins (2008) Cancer Lett, 269, pp. 199-225. , 18479807 10.1016/j.canlet.2008.03.009 1:CAS:528:DC%2BD1cXhtFWlsrjM | ||
| 504 | |a Gupta, S.C., Kim, J.H., Prasad, S., Aggarwal, B.B., Regulation of survival, proliferation, invasion, angiogenesis and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals (2010) Cancer Metastasis Rev, 29, pp. 405-434. , 20737283 10.1007/s10555-010-9235-2 1:CAS:528:DC%2BC3cXhtFWqt7vN | ||
| 504 | |a James, M.F., Han, S., Polizzano, C., Plotkin, S.R., Manning, B.D., Stemmer-Rachaminmov, A.O., Gusella, J.F., Ramesh, V., NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth (2009) Mol Cell Biol, 29, pp. 4250-4261. , 19451225 10.1128/MCB.01581-08 1:CAS:528:DC%2BD1MXptFehtrk%3D | ||
| 504 | |a Angelo, L.S., Wu, Y.J., Meng, F., Sun, M., Kopetz, S., McCutcheon, I.E., Slopis, J.M., Kurzrock, R., Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: Analysis of response and resistance pathways (2011) Mol Cancer Ther, 10, pp. 2094-2103. , 21903608 10.1158/1535-7163.MCT-11-0243 1:CAS:528:DC%2BC3MXhsVeltLfN | ||
| 504 | |a Pagotto, U., Arzberger, T., Hopfner, U., Sauer, J., Renner, U., Newton, C.J., Lange, M., Stalla, G.K., Expression and localization of endothelin-1 and endothelin receptors in human meningiomas: Evidence for a role in tumoral growth (1995) J Clin Invest, 96, pp. 2017-2025. , 7560095 10.1172/JCI118249 1:CAS:528:DyaK2MXosFyhtL0%3D | ||
| 504 | |a Schaaf, C., Shan, B., Buchfelder, M., Losa, M., Kreutzer, J., Rachinger, W., Stalla, G.K., Renner, U., Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo (2009) Endocr Rel Cancer, 16, pp. 1339-1350. , 10.1677/ERC-09-0129 1:CAS:528:DC%2BC3cXhtFOnsrY%3D | ||
| 504 | |a Tichomirowa, M., Theodoropoulou, M., Daly, A.F., Yassourides, A., Hansen, S., Lu, J., Lange, M., Renner, U., Toll-like receptor 4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel (2008) Int J Cancer, 123, pp. 1956-1963. , 18688857 10.1002/ijc.23737 1:CAS:528:DC%2BD1cXhtFKgsr3I | ||
| 504 | |a Shezad, A., Wahid, F., Lee, Y.S., Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials (2010) Arch Pharm Chem Life Sci, 9, pp. 489-499. , 10.1002/ardp.200900319 | ||
| 504 | |a Gupta, S.C., Prasad, S., Kim, J.H., Patchva, S., Webb, L.J., Priyadarsini, I.K., Aggarwal, B.B., Multitargeting by curcumin as revealed by molecular interaction studies (2011) Nat Prod Rep, 28, pp. 1937-1955. , 21979811 10.1039/c1np00051a 1:CAS:528:DC%2BC3MXhsVOjt7rF | ||
| 504 | |a Yadav, V.R., Aggarwal, B.B., Curcumin: A component of the golden spice, targets multiple angiogenic pathways (2011) Cancer Biol Ther, 11, pp. 236-241. , 21191188 10.4161/cbt.11.2.14405 1:CAS:528:DC%2BC3MXislyhurg%3D | ||
| 504 | |a Sung, B., Prasad, S., Yadav, V.R., Aggarwal, B.B., Cancer cell signaling pathways targeted by spice-derived nutraceuticals (2012) Nutr Cancer, 64, pp. 173-197. , 22149093 10.1080/01635581.2012.630551 1:CAS:528:DC%2BC38XisFWrsrk%3D | ||
| 504 | |a Schaaf, C., Shan, B., Onofri, C., Stalla, G.K., Arzt, E., Schilling, T., Perone, M.J., Renner, U., Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells (2010) Neuroendocrinology, 91, pp. 200-210. , 20160430 10.1159/000287236 1:CAS:528:DC%2BC3cXjs12lsrs%3D | ||
| 504 | |a Aoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B.B., Kondo, Y., Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways (2007) Mol Pharmacol, 72, pp. 29-39. , 17395690 10.1124/mol.106.033167 1:CAS:528:DC%2BD2sXnsVyjs7Y%3D | ||
| 504 | |a Weir, N.M., Selvendiran, K., Kutala, V.K., Tong, L., Vishwanath, S., Rajaram, M., Tridandapani, S., Kuppusamy, P., Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK (2007) Cancer Biol Ther, 6, pp. 178-184. , 17218783 10.4161/cbt.6.2.3577 1:CAS:528:DC%2BD2sXhtVeqsbzI | ||
| 504 | |a Lee, S.J., Krauthauser, C., Maduskuie, V., Fawcett, P.T., Olson, J.M., Rajasekaran, S.A., Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo (2011) BMC Cancer, 11, pp. 144-152. , 21501498 10.1186/1471-2407-11-144 1:CAS:528:DC%2BC3MXltFKlu7w%3D | ||
| 504 | |a Lim, K.J., Bisht, S., Bar, E.E., Maitra, A., Eberhart, C.G., A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors (2001) Cancer Biol Ther, 11, pp. 464-473 | ||
| 504 | |a Liu, H.-S., Ke, C.-S., Cheng, H.-C., Huang, C.-Y., Su, C.-L., Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of Aurora A (2011) Mol Pharmacol, 80, pp. 638-648. , 21757545 10.1124/mol.111.072512 1:CAS:528:DC%2BC3MXhs1ansbjN | ||
| 504 | |a Zanotto-Filho, A., Braganhol, E., Edelweiss, M., Behr, G.A., Zanin, R., Schröder, R., Simoes-Pires, A., Moreira, J.C., The curry spice curcumin selectively inhibits cancer cell growth in vitro and in a preclinical model of glioblastoma (2012) J Nutr Biochem, 23, pp. 591-601. , 21775121 10.1016/j.jnutbio.2011.02.015 1:CAS:528:DC%2BC38XntFagt70%3D | ||
| 504 | |a Karunagaran, D., Joseph, J., Kumar, T.R., Cell growth regulation (2007) Adv Exp Med Biol, 595, pp. 245-268. , 17569215 10.1007/978-0-387-46401-5-11 | ||
| 504 | |a Lee, S.J., Langhans, S.A., Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis (2012) BMC Cancer, 12, pp. 44-56. , 22280307 10.1186/1471-2407-12-44 1:CAS:528:DC%2BC38XksFGksbo%3D | ||
| 504 | |a Shishodia, S., Amin, H.M., Lai, R., Aggarwal, B.B., Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma (2005) Biochem Pharmacol, 70, pp. 700-713. , 16023083 10.1016/j.bcp.2005.04.043 1:CAS:528:DC%2BD2MXmvFSis74%3D | ||
| 504 | |a Srivastava, R.K., Chen, Q., Siddiqui, I., Sarva, K., Shankar, S., Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21/waf1/cip (2007) Cell Cycle, 6, pp. 2953-2961. , 18156803 10.4161/cc.6.23.4951 1:CAS:528:DC%2BD1cXhsFOltbk%3D | ||
| 504 | |a Teiten, M.-H., Gaascht, F., Cronauer, M., Henry, E., Dicato, M., Diederich, M., Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway (2011) Int J Cancer, 38, pp. 603-611. , 1:CAS:528:DC%2BC3MXjsFWnsLo%3D | ||
| 504 | |a Wu, J.C., Lai, C.S., Badmaev, V., Nagabhushanam, K., Ho, C.T., Pan, M.H., Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3 K/Akt-mTOR and MAPK signaling pathways in human leukemia HL 60 cells (2011) Mol Nutr Food Res, 55, pp. 1646-1654. , 21928294 10.1002/mnfr.201100454 1:CAS:528:DC%2BC3MXhsVShsrvK | ||
| 504 | |a Jia, Y.L., Li, J., Qin, Z.H., Liang, Z.Q., Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells (2009) J Asian Nat Prod Res, 11, pp. 918-928. , 20183254 10.1080/10286020903264077 1:CAS:528:DC%2BD1MXhsVyju7vI | ||
| 504 | |a Qian, H., Yang, Y., Wang, X., Curcumin enhanced adriamycin-indued human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy (2011) Eur J Pharmacol Sci, 43, pp. 125-131. , 10.1016/j.ejps.2011.04.002 1:CAS:528:DC%2BC3MXmvFSkt7o%3D | ||
| 504 | |a Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: Problems and promises (2007) Mol Pharm, 4, pp. 807-818. , 17999464 10.1021/mp700113r 1:CAS:528:DC%2BD2sXht12gsrnF | ||
| 504 | |a Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Yo, Y.F., Shen, T.S., Ko, J.Y., Jee, S.H., Phase i clinical trial of curcumin, a chemopreventive agent in patients with high-risk of pre-malignant lesions (2001) Anticancer Res, 21, pp. 2895-2900. , 1:CAS:528:DC%2BD3MXovVWgtrg%3D | ||
| 504 | |a Sharma, R.A., Euden, S.A., Patton, S.L., Cooke, D.N., Shafayat, A., Hewitt, H.R., Marczylo, T.H., Gescher, A.J., Phase i clinical trial of curcumin: Biomarkers of systemic activity and compliance (2004) Clin Cancer Res, 10, pp. 6847-6854. , 15501961 10.1158/1078-0432.CCR-04-0744 1:CAS:528:DC%2BD2cXpslGltLg%3D | ||
| 504 | |a Garcea, G., Jones, D.J., Singh, R., Dennison, A.R., Farmer, P.B., Sharma, R.A., Steward, W.P., Berry, D.P., Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration (2004) Br J Cancer, 90, pp. 1011-1015. , 14997198 10.1038/sj.bjc.6601623 1:CAS:528:DC%2BD2cXhslWrsLw%3D | ||
| 504 | |a Thomas, S.L., Zhong, D., Zhou, W., Malik, S., Liotta, D., Snyder, J.P., Hamel, E., Giannakakou, P., EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1 (2008) Cell Cycle, 7, pp. 2409-2417. , 18682687 1:CAS:528:DC%2BD1cXht1SgtLrM | ||
| 504 | |a Li, J., Wang, Y., Yang, C., Wang, P., Oelschlager, D.K., Zheng, Y., Tian, D.-A., Wan, M., Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1 (2009) Mol Pharmacol, 76, pp. 81-90. , 19395473 10.1124/mol.109.054551 1:CAS:528:DC%2BD1MXos1amtrc%3D | ||
| 504 | |a Selvendiran, K., Kuppusamy, M.L., Bratasz, A., Tong, L., Rivera, B.K., Rink, C., Sen, C.K., Kuppusamy, P., Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcumoid, through up-regulation of PTEN expression (2009) J Pharmacol Exp Ther, 329, pp. 959-966. , 19276401 10.1124/jpet.108.150367 1:CAS:528:DC%2BD1MXms1ehurk%3D | ||
| 504 | |a Shahani, K., Swaminathan, S.K., Freeman, D., Blum, A., Ma, L., Panyam, J., Injectable sustained release microparticles of curcumin: A new concept for cancer chemoprevention (2010) Cancer Res, 70, pp. 4443-4452. , 20460537 10.1158/0008-5472.CAN-09-4362 1:CAS:528:DC%2BC3cXmslWgtrc%3D | ||
| 520 | 3 | |a Meningiomas, the most frequent benign intracranial and intraspinal types of tumors are normally removed by surgery. Complications can occur when the tumor is critically localized and cannot be completely removed or when comorbidities of the mostly elder patients increase the general surgical risk. Thus, alternate medical treatment concepts for the therapy of meningiomas would be desirable. Curcumin, the active ingredient of the spice plant Curcuma longa has shown anti-tumorigenic actions in many different types of tumors and therefore, its effect on growth and apoptosis of meningioma cells was studied in the present paper. In vitro, treatment of the human Ben-Men-1 meningioma cell line and of a series of 21 primary human meningioma cell cultures with curcumin (1-20 μM) strongly reduced the proliferation in all cases in a dose dependent manner. Cell cycle analysis by fluorescence-activated cell sorting showed growth arrest at G2/M phase, which was confirmed by demonstrating the corresponding modulation of proteins involved in G2/M arrest by immunoblotting and/or confocal laser microscopy. High dosages (20, 50 μM) of curcumin induced a significant increase of apoptosis in Ben-Men-1 and primary meningioma cell cultures as demonstrated by morphological changes of cell nuclei, DNA fragmentation, translocation of cell membrane associated phosphatidyl serine and the induction of apoptotic-acting cleaved caspase-3. Our results suggest that the multi-targeting drug curcumin has potent anti-tumorigenic actions in meningioma cells and might therefore be a putative candidate for the pharmacological treatment of meningiomas. © 2013 Springer Science+Business Media New York. |l eng | |
| 593 | |a Max Planck Institute of Psychiatry, Clinical Neuroendocrinology Group, Kraepelinstr. 10, 80804 Munich, Germany | ||
| 593 | |a Neurosurgical Department of the Clinic, Villingen-Schwenningen, Villingen-Schwenningen, Germany | ||
| 593 | |a Neurosurgical Clinic, Technical University Munich, Munichm, Germany | ||
| 593 | |a IBioBA-CONICET-Max Planck Partner Institute, Buenos Aires, Argentina | ||
| 593 | |a Departamento de Fisiología y Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a APOPTOSIS |
| 690 | 1 | 0 | |a CURCUMIN |
| 690 | 1 | 0 | |a G2/M PHASE CELL CYCLE ARREST |
| 690 | 1 | 0 | |a MENINGIOMA |
| 690 | 1 | 0 | |a PROLIFERATION |
| 690 | 1 | 0 | |a CASPASE 3 |
| 690 | 1 | 0 | |a CURCUMIN |
| 690 | 1 | 0 | |a PHOSPHATIDYLSERINE |
| 690 | 1 | 0 | |a THYMIDINE |
| 690 | 1 | 0 | |a ANTINEOPLASTIC AGENT |
| 690 | 1 | 0 | |a CURCUMIN |
| 690 | 1 | 0 | |a ADULT |
| 690 | 1 | 0 | |a AGED |
| 690 | 1 | 0 | |a ANTINEOPLASTIC ACTIVITY |
| 690 | 1 | 0 | |a ANTIPROLIFERATIVE ACTIVITY |
| 690 | 1 | 0 | |a APOPTOSIS |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CANCER CELL CULTURE |
| 690 | 1 | 0 | |a CELL CYCLE ARREST |
| 690 | 1 | 0 | |a CELL MEMBRANE |
| 690 | 1 | 0 | |a CELL TRANSPORT |
| 690 | 1 | 0 | |a CONCENTRATION RESPONSE |
| 690 | 1 | 0 | |a CONFOCAL LASER MICROSCOPY |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DNA FRAGMENTATION |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a FLOW CYTOMETRY |
| 690 | 1 | 0 | |a FLUORESCENCE ACTIVATED CELL SORTING |
| 690 | 1 | 0 | |a G2 PHASE CELL CYCLE CHECKPOINT |
| 690 | 1 | 0 | |a GENE TRANSLOCATION |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a HUMAN TISSUE |
| 690 | 1 | 0 | |a IMMUNOBLOTTING |
| 690 | 1 | 0 | |a IMMUNOFLUORESCENCE TEST |
| 690 | 1 | 0 | |a IN VITRO STUDY |
| 690 | 1 | 0 | |a MALE |
| 690 | 1 | 0 | |a MENINGIOMA |
| 690 | 1 | 0 | |a WESTERN BLOTTING |
| 690 | 1 | 0 | |a APOPTOSIS |
| 690 | 1 | 0 | |a CELL CYCLE |
| 690 | 1 | 0 | |a CELL PROLIFERATION |
| 690 | 1 | 0 | |a DRUG EFFECTS |
| 690 | 1 | 0 | |a FLUORESCENT ANTIBODY TECHNIQUE |
| 690 | 1 | 0 | |a MENINGIOMA |
| 690 | 1 | 0 | |a METABOLISM |
| 690 | 1 | 0 | |a PATHOLOGY |
| 690 | 1 | 0 | |a TUMOR CELL CULTURE |
| 690 | 1 | 0 | |a ANTINEOPLASTIC AGENTS |
| 690 | 1 | 0 | |a APOPTOSIS |
| 690 | 1 | 0 | |a BLOTTING, WESTERN |
| 690 | 1 | 0 | |a CELL CYCLE |
| 690 | 1 | 0 | |a CELL PROLIFERATION |
| 690 | 1 | 0 | |a CURCUMIN |
| 690 | 1 | 0 | |a FLOW CYTOMETRY |
| 690 | 1 | 0 | |a FLUORESCENT ANTIBODY TECHNIQUE |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a MENINGEAL NEOPLASMS |
| 690 | 1 | 0 | |a MENINGIOMA |
| 690 | 1 | 0 | |a TUMOR CELLS, CULTURED |
| 653 | 0 | 0 | |a curcumin, Sigma, United States |
| 700 | 1 | |a Wu, Y. | |
| 700 | 1 | |a Shan, B. | |
| 700 | 1 | |a Schaaf, C. | |
| 700 | 1 | |a Utpadel, D. | |
| 700 | 1 | |a Lange, M. | |
| 700 | 1 | |a Kuhlen, D. | |
| 700 | 1 | |a Perone, M.J. | |
| 700 | 1 | |a Arzt, E. | |
| 700 | 1 | |a Stalla, G.K. | |
| 700 | 1 | |a Renner, U. | |
| 773 | 0 | |d Springer New York LLC, 2013 |g v. 113 |h pp. 385-396 |k n. 3 |p J. Neuro-Oncol. |x 0167594X |t Journal of Neuro-Oncology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879341119&doi=10.1007%2fs11060-013-1148-9&partnerID=40&md5=498370d3092eae69194282231bd2f665 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s11060-013-1148-9 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_0167594X_v113_n3_p385_Curic |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0167594X_v113_n3_p385_Curic |y Registro en la Biblioteca Digital |
| 961 | |a paper_0167594X_v113_n3_p385_Curic |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 72418 | ||